Genmab A/S
MONOCLONAL ANTIBODIES AGAINST C-MET

Last updated:

Abstract:

Isolated monoclonal antibodies which bind to human c-Met, the hepatocyte growth factor receptor, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.

Status:
Application
Type:

Utility

Filling date:

23 Aug 2019

Issue date:

12 Mar 2020